Our formulation facility at Dahej was inspected by US FDA from July 23-27, 2018. At the end of the inspection, no Form 483 was issued to us, said Ajanta Pharma.
from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2On0jn8
via IFTTT
Home »
Healthcare/Biotech-Industry-The Economic Times
» USFDA inspects Dahej facility, no observations issued: Ajanta Pharma
0 comments:
Post a Comment